Omalizumab: From IgE to anti-IgE in asthma and allergic reactions;Bei asthma und allergischen reaktionen - Omalizumab: Vom IgE zum anti-IgE

Pharmazie in Unserer Zeit

Volumn 33, Issue 2, 2004, Pages 116-122

  Ladetzki Baehs, Kathrin ^b   Dirsch, Verena M ^b   Vollmar, Angelika M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; MONOCLONAL ANTIBODY; OMALIZUMAB;

ALLERGIC DISEASE; ALLERGIC REACTION; ASTHMA; EOSINOPHIL; LEUKOCYTE; REVIEW; ANIMAL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E;

EID: 2342538433     PISSN: 00483664     EISSN: None     Source Type: Journal    
DOI: 10.1002/pauz.200400062     Document Type: Review

References (19)

1. Hamelmann, E., Rolinck-Werninghaus, C., and Wahn, U. From IgE to anti-IgE: where do we stand? Allergy, 57: 983-994, 2002
2. Ishizaka, K., Ishizaka, T., and Hornbrook, M. M. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J. Immunol., 97: 75-85, 1966.
3. Ishizaka, K. and Ishizaka, T. Identification of gamma-E-antibodies as a carrier of reaginic activity. J. Immunol., 99: 1187-1198, 1967.
4. Johansson, S. C. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet. 2: 951-953, 1967.
5. Chang, T. W. The pharmacological basis of anti-IgE therapy. Nat. Biotechnol., 18: 157-162, 2000.
6. Finn, A., Gross, G., van Bavel, J., Lee, T., Windom, H., Everhard, F., Fowler-Taylor, A., Liu, J., and Gupta, N. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J. Allergy Clin. Immunol., 111: 278-284, 2003.
7. Diseases of Immunity. In Cotran, Kumar, and Collins (eds.), Pathologic Basis of Disease, 6 ed, pp. 188-259. Philadelphia: W.B. Saunders Company, 1999.
8. Skoner, D. P. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol., 108: S2-S8, 2001.
9. Bush, R. K. The use of anti-IgE in the treatment of allergic asthma. Med. Clin. North Am., 86: 1113-1129, 2002.
10. Busse, W. W. and Rosenwasser, L. J. Mechanisms of asthma. J. Allergy Clin. Immunol., 111: S799-S804, 2003.
11. Coyle, A. J., Wagner, K., Bertrand, C., Tsuyuki, S., Bews, J., and Heusser, C. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody. J. Exp. Med., 183: 1303-1310, 1996.
12. Broide, D. H. Molecular and cellular mechanisms of allergic disease. J. Allergy Clin. Immunol., 108: S65-S71, 2001.
13. Berger, W. E. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease. Ann. Allergy Asthma Immunol., 88: 152-160, 2002.
14. Johansson, S. G., Haahtela, T., and O'Byrne, P. M. Omalizumab and the immune system: an overview of preclinical and clinical data. Ann. Allergy Asthma Immunol., 89: 132-138, 2002.
15. Spector, S. L. Allergic inflammation in upper and lower airways. Ann. Allergy Asthma Immunol., 83: 435-444, 1999.
16. Chang, T. W., Davis, F. M., Sun, N. C. Sun, C. R., MacGlashan, D. W., Jr., and Hamilton, R. G. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology (N.Y.). 8: 122-126, 1990.
17. Presta, L. G., Lahr, S. J., Shields, R. L. Porter, J. P., Gorman, C. M., Fendly, B. M., and Jardieu, P. M. Humanization of an antibody directed against IgE. J. Immunol., 151: 2623-2632, 1993.
18. Davis, F. M., Gossett, L. A., Pinkston, K. L. Liou, R. S., Sun, L. K., Kim, Y. W., Chang, N. T., Chang, T. W., Wagner, K., Bews, J., and. Can anti-IgE be used to treat allergy? Springer Semin. Immunopathol., 15: 51-73, 1993.
19. Lanier, B. Q. Newer aspects in the treatment of pediatric and adult asthma: monoclonal anti-IgE. Ann. Allergy Asthma Immunol., 90: 13-15, 2003.